A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers (Q33587452)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers |
scientific article |
Statements
1 reference
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers (English)
1 reference
Charles L Raison
1 reference
Robin E Rutherford
1 reference
Chen Shuo
1 reference
Pamela Schettler
1 reference
Daniel F Drake
1 reference
Andrew H Miller
1 reference
1 January 2013
1 reference
1 reference
70
1 reference
31-41
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference